V-Card | Print | PDF | Email Page

Jerry C. Ling


(T) +1.415.875.5890
(F) +1.415.875.5700
(T) +86.21.2201.8000
(F) +86.21.5298.6569


  • Harvard University (J.D. magna cum laude 2003); Dartmouth College (A.B. in Biology magna cum laude 2000)

Bar Admissions

  • California, Hawaii, U.S. Court of Appeals for the Ninth Circuit, and U.S. District Court for the District of Hawaii


  • Law Clerk to the Honorable Richard R. Clifton, United States Court of Appeals, Ninth Circuit (2004)

For more than a decade, Jerry Ling has litigated and arbitrated intellectual property and commercial contract disputes and has led investigations into alleged violations of the FCPA and other anticorruption laws for clients operating in China and the Asia-Pacific region.

Jerry has arbitrated breach of contract claims for a global private equity fund in Hong Kong, defended a major telecom manufacturer against patent infringement lawsuits filed in China, and brought trade secret claims on behalf of a global retailer in simultaneous actions across the Asia-Pacific region. He also handles complex U.S. litigation and recently represented a leading technology company in an antitrust dispute in the United States.

Jerry was previously based in Shanghai for 10 years, where he led numerous investigations involving corruption, intellectual property theft, and conflicts of interest. He recently assisted several U.S.-listed companies in responding to government inquiries into FCPA violations in China and Southeast Asia. He frequently leads compliance risk assessments for multinationals with significant operations throughout Asia-Pacific and provides compliance training for Asia-Pacific and global leadership teams.

Jerry also has extensive experience advising clients on their mergers and acquisitions in Asia, including conducting anticorruption due diligence for acquisitions. Representative matters include advising Cardinal Health in its acquisition of Johnson & Johnson's Cordis business for US$1.9 billion, Procter & Gamble's acquisition of Sara Lee's Ambi Pur business for US$470 million, and Textron's sale of its Fluid & Power product lines for US$645 million.

Honors & Distinctions

  • The Legal 500 Asia Pacific (2015) — top-tier recommendation: China: dispute resolution

    Chambers Asia-Pacific (2016-2017) — recognized in the area of corporate investigation, where he attracts plaudits from numerous sources, with one revealing that "he's thorough, he's practical, he's a very good investigator, and he's client-centric," while another simply says, "I think he's fantastic"
Jerry Ling